153 related articles for article (PubMed ID: 17306832)
1. Probability of resistance evolution for exponentially growing virus in the host.
Haeno H; Iwasa Y
J Theor Biol; 2007 May; 246(2):323-31. PubMed ID: 17306832
[TBL] [Abstract][Full Text] [Related]
2. HIV-resistance evolution requires new strategies. Mutation risk higher if HIV RNA increases.
AIDS Alert; 2005 Jan; 20(1):3. PubMed ID: 15717352
[TBL] [Abstract][Full Text] [Related]
3. Antiviral resistance and impact on viral replication capacity: evolution of viruses under antiviral pressure occurs in three phases.
Nijhuis M; van Maarseveen NM; Boucher CA
Handb Exp Pharmacol; 2009; (189):299-320. PubMed ID: 19048205
[TBL] [Abstract][Full Text] [Related]
4. Dynamic patterns of human immunodeficiency virus type 1 integrase gene evolution in patients failing raltegravir-based salvage therapies.
Canducci F; Sampaolo M; Marinozzi MC; Boeri E; Spagnuolo V; Galli A; Castagna A; Lazzarin A; Clementi M; Gianotti N
AIDS; 2009 Feb; 23(4):455-60. PubMed ID: 19165083
[TBL] [Abstract][Full Text] [Related]
5. Emergence of HIV-1 drug resistance during antiretroviral treatment.
Rong L; Feng Z; Perelson AS
Bull Math Biol; 2007 Aug; 69(6):2027-60. PubMed ID: 17450401
[TBL] [Abstract][Full Text] [Related]
6. Recombination in HIV and the evolution of drug resistance: for better or for worse?
Bretscher MT; Althaus CL; Müller V; Bonhoeffer S
Bioessays; 2004 Feb; 26(2):180-8. PubMed ID: 14745836
[TBL] [Abstract][Full Text] [Related]
7. Drug induced superinfection in HIV and the evolution of drug resistance.
Leontiev VV; Maury WJ; Hadany L
Infect Genet Evol; 2008 Jan; 8(1):40-50. PubMed ID: 18024234
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance.
de Mendoza C; Rodriguez C; García F; Eiros JM; Ruíz L; Caballero E; Aguilera A; Leiva P; Colomina J; Gutierrez F; del Romero J; Aguero J; Soriano V;
J Antimicrob Chemother; 2007 Apr; 59(4):698-704. PubMed ID: 17327295
[TBL] [Abstract][Full Text] [Related]
9. Both human immunodeficiency virus cellular DNA sequencing and plasma RNA sequencing are useful for detection of drug resistance mutations in blood samples from antiretroviral-drug-naive patients.
Parisi SG; Boldrin C; Cruciani M; Nicolini G; Cerbaro I; Manfrin V; Dal Bello F; Franchin E; Franzetti M; Rossi MC; Cattelan AM; Romano L; Zazzi M; Andreoni M; Palù G
J Clin Microbiol; 2007 Jun; 45(6):1783-8. PubMed ID: 17442799
[TBL] [Abstract][Full Text] [Related]
10. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
[TBL] [Abstract][Full Text] [Related]
11. Long-term immunologic and virologic responses in patients with highly resistant HIV infection who are treated with an incompletely suppressive antiretroviral regimen.
Gandhi T; Nagappan V; Cinti S; Wei W; Kazanjian P
Clin Infect Dis; 2007 Oct; 45(8):1085-92. PubMed ID: 17879930
[TBL] [Abstract][Full Text] [Related]
12. Modeling within-host evolution of HIV: mutation, competition and strain replacement.
Ball CL; Gilchrist MA; Coombs D
Bull Math Biol; 2007 Oct; 69(7):2361-85. PubMed ID: 17554585
[TBL] [Abstract][Full Text] [Related]
13. Defective deletion mutant amplification.
McLeod B; Burroughs N
J Theor Biol; 2000 Oct; 206(4):449-64. PubMed ID: 11013108
[TBL] [Abstract][Full Text] [Related]
14. Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy.
Peuchant O; Thiébaut R; Capdepont S; Lavignolle-Aurillac V; Neau D; Morlat P; Dabis F; Fleury H; Masquelier B;
AIDS; 2008 Jul; 22(12):1417-23. PubMed ID: 18614864
[TBL] [Abstract][Full Text] [Related]
15. [Detection of primary antiretroviral resistance in Chilean patients recently infected with human immunodeficiency virus (HIV)].
Acevedo W; Gallardo AM; Galaz J; Afani A; Cortés E
Rev Med Chil; 2007 Nov; 135(11):1406-13. PubMed ID: 18259651
[TBL] [Abstract][Full Text] [Related]
16. Declining prevalence of HIV-1 drug resistance in treatment-failing patients: a clinical cohort study.
Di Giambenedetto S; Bracciale L; Colafigli M; Cattani P; Pinnetti C; Bacarelli A; Prosperi M; Fadda G; Cauda R; De Luca A
Antivir Ther; 2007; 12(5):835-9. PubMed ID: 17713168
[TBL] [Abstract][Full Text] [Related]
17. [The origin and evolution of viruses].
Rødahl E
Nord Med; 1990; 105(2):54-7. PubMed ID: 2304837
[TBL] [Abstract][Full Text] [Related]
18. Impact of genotypic drug resistance mutations on clinical and immunological outcomes in HIV-infected adults on HAART in West Africa.
Seyler C; Adjé-Touré C; Messou E; Dakoury-Dogbo N; Rouet F; Gabillard D; Nolan M; Toure S; Anglaret X
AIDS; 2007 May; 21(9):1157-64. PubMed ID: 17502726
[TBL] [Abstract][Full Text] [Related]
19. Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients.
Selabe SG; Lukhwareni A; Song E; Leeuw YG; Burnett RJ; Mphahlele MJ
J Med Virol; 2007 Nov; 79(11):1650-4. PubMed ID: 17854040
[TBL] [Abstract][Full Text] [Related]
20. Competitive capacity of HIV-1 strains carrying M184I or Y181I drug-resistant mutations.
Li J; Li L; Li HP; Zhuang DM; Liu SY; Liu YJ; Bao ZY; Wang Z; Li JY
Chin Med J (Engl); 2009 May; 122(9):1081-6. PubMed ID: 19493444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
